Cargando…
Antenatal Indomethacin Treatment for Congenital Myotonic Dystrophy
Myotonic dystrophy is an autosomal-dominant disorder. Its congenital type is the most severe form, with respiratory failure that can be a life-threatening event after birth. There are no antenatal treatments that can improve neonatal outcomes of myotonic dystrophy. We treated a fetus with congenital...
Autores principales: | Yamaguchi, Kyohei, Tanaka, Hiroaki, Furuhashi, Fumi H., Tanaka, Kayo, Kondo, Eiji, Ikeda, Tomoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393864/ https://www.ncbi.nlm.nih.gov/pubmed/30906607 http://dx.doi.org/10.1155/2019/4290145 |
Ejemplares similares
-
Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011) -
Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009) -
Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017) -
Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy
por: Tanaka, Naoki, et al.
Publicado: (2020) -
Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)